Digital illustration of a compass with a purple background.

ABOUT US

Proven track record of bringing new therapies to patients

The Navigator leadership and Navigator crew have successfully steered the development of multiple new treatments for inflammatory disorders and autoimmune diseases. We understand what it takes to advance science from research to remedy to help people living with difficult to treat conditions and are working at pace to bring meaningful new therapies to patients as quickly as possible.

Our MISSON

To leverage high confidence mechanisms through the development of multispecific and/or T1/2 extended biologics targeting established pathways .

LEADERSHIP TEAM

A middle-aged man with short gray hair, wearing a light blue dress shirt, smiling gently at the camera, with a blurred indoor background.

Tausif ‘Tosh’ Butt
CEO and President

A woman with blonde hair wearing a dark blue blouse and a beaded necklace, posing for a professional portrait with a blurred background.

Kristie Grebe, PhD
Chief Scientific Officer
Head of Research & Development

A man with short dark hair wearing a light-colored checkered shirt, smiling at the camera against a blurred background.

Scott Forrest, PhD
Chief Financial Officer

BOARD OF DIRECTORS

Our Board of Directors, comprised of biotech and venture capital leaders, bring deep expertise and strong governance as we navigate the next phase of our pipeline development and company growth.

Our VISION

Khurem Farooq, MBA - Board Chair
Co-Founder and CEO, Verdiva Bio

Tausif “Tosh” Butt
CEO and President, Navigator Medicines

Wouter Joustra, MSc
General Partner, Forbion

Stephen Thomas, PhD
Co-Founder and CEO, Sera Medicine

INVESTORS

We are proud to partner with impact-driven investors who are committed to helping realize the potential of bispecific antibody development for inflammatory disorders and autoimmune disease.